Samuel A Silver1,2, Jin Long1, Yuanchao Zheng1, Glenn M Chertow1. 1. Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA, USA. 2. Division of Nephrology, University of Toronto, Toronto, Canada.
Abstract
BACKGROUND: The economic burden of acute kidney injury (AKI) is not well understood. OBJECTIVE: To estimate the effects of AKI on hospitalization costs and length of stay (LOS). DESIGN: Using data from the 2012 National Inpatient Sample, we compared hospitalization costs and LOS with and without AKI. We used a generalized linear model with a gamma distribution and a log link fitted to AKI to adjust for demographics, hospital differences, and comorbidities. SETTING: United States. PATIENTS: 29,763,649 adult hospitalizations without endstage renal disease. EXPOSURE: AKI determined using International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) diagnosis codes.. MEASUREMENTS: Hospitalization costs and LOS. RESULTS: AKI was associated with an increase in hospitalization costs of $7933 (95% confidence interval [CI], $7608-$8258) and an increase in LOS of 3.2 (95% CI, 3.2-3.3) days compared to patients without AKI. When adjusted for patient and hospital characteristics, the associated increase in costs was $1795 (95% CI, $1692-$1899) and in LOS, it was 1.1 (95% CI, 1.1-1.1) days. Corresponding results among patients hospitalized with AKI requiring dialysis were $42,077 (95% CI, $39,820-$44,335) and 11.5 (95% CI, 11.2-11.8) days and $11,016 (95% CI, $10,468-$11,564) and 3.9 (95% CI, 3.8-4.1) days. AKI was associated with higher hospitalization costs than myocardial infarction and gastrointestinal bleeding, and costs were comparable to those for stroke, pancreatitis, and pneumonia.. CONCLUSIONS: In the United States, AKI is associated with excess hospitalization costs and prolonged LOS. The economic burden of AKI warrants further attention from hospitals and policymakers to enhance processes of care and develop novel treatment strategies. Journal of Hospital Medicine 2017;12:70-76.
BACKGROUND: The economic burden of acute kidney injury (AKI) is not well understood. OBJECTIVE: To estimate the effects of AKI on hospitalization costs and length of stay (LOS). DESIGN: Using data from the 2012 National Inpatient Sample, we compared hospitalization costs and LOS with and without AKI. We used a generalized linear model with a gamma distribution and a log link fitted to AKI to adjust for demographics, hospital differences, and comorbidities. SETTING: United States. PATIENTS: 29,763,649 adult hospitalizations without endstage renal disease. EXPOSURE: AKI determined using International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) diagnosis codes.. MEASUREMENTS: Hospitalization costs and LOS. RESULTS: AKI was associated with an increase in hospitalization costs of $7933 (95% confidence interval [CI], $7608-$8258) and an increase in LOS of 3.2 (95% CI, 3.2-3.3) days compared to patients without AKI. When adjusted for patient and hospital characteristics, the associated increase in costs was $1795 (95% CI, $1692-$1899) and in LOS, it was 1.1 (95% CI, 1.1-1.1) days. Corresponding results among patients hospitalized with AKI requiring dialysis were $42,077 (95% CI, $39,820-$44,335) and 11.5 (95% CI, 11.2-11.8) days and $11,016 (95% CI, $10,468-$11,564) and 3.9 (95% CI, 3.8-4.1) days. AKI was associated with higher hospitalization costs than myocardial infarction and gastrointestinal bleeding, and costs were comparable to those for stroke, pancreatitis, and pneumonia.. CONCLUSIONS: In the United States, AKI is associated with excess hospitalization costs and prolonged LOS. The economic burden of AKI warrants further attention from hospitals and policymakers to enhance processes of care and develop novel treatment strategies. Journal of Hospital Medicine 2017;12:70-76.
Authors: Ciara M Shaver; Melinda G Paul; Nathan D Putz; Stuart R Landstreet; Jamie L Kuck; Lauren Scarfe; Nataliya Skrypnyk; Haichun Yang; Fiona E Harrison; Mark P de Caestecker; Julie A Bastarache; Lorraine B Ware Journal: Am J Physiol Renal Physiol Date: 2019-07-31
Authors: Kathleen D Liu; Jingrong Yang; Thida C Tan; David V Glidden; Sijie Zheng; Leonid Pravoverov; Chi-Yuan Hsu; Alan S Go Journal: Am J Kidney Dis Date: 2018-10-25 Impact factor: 8.860
Authors: Christina Bradshaw; Yuanchao Zheng; Samuel A Silver; Glenn M Chertow; Jin Long; Shuchi Anand Journal: J Gen Intern Med Date: 2018-06-18 Impact factor: 5.128
Authors: Kevin W Lobdell; Devin M Parker; Donald S Likosky; Michael Rezaee; Moritz Wyler von Ballmoos; Shama S Alam; Sherry Owens; Heather Thiessen-Philbrook; Todd MacKenzie; Jeremiah R Brown Journal: J Thorac Cardiovasc Surg Date: 2018-04-11 Impact factor: 5.209
Authors: Yang Xu; Aditya Surapaneni; Jim Alkas; Marie Evans; Jung-Im Shin; Elizabeth Selvin; Alex Chang; Morgan E Grams; Juan Jesus Carrero Journal: Diabetes Care Date: 2020-10-06 Impact factor: 19.112